Great news for individuals suffering from prostate cancer and men’s health advocates everywhere, as this week the FDA-approved a new treatment for men with the advanced stage of the disease. The vaccine, called Provenge, is not a traditional preventive cancer vaccine (such as those for cervical cancer), but rather boosts the patient’s immune system to...Continue reading
Tag: Provenge
Medicare Evidence Development and Coverage Advisory Committee Recommends Medicare Reimbursement of Provenge
Yesterday, the Medicare Evidence Development and Coverage Advisory Committee’s (MEDCAC) vote on a number of questions amounted to a recommendation to the Centers for Medicare and Medicaid Services (CMS) to cover Provenge, a therapeutic vaccine for men with advanced prostate cancer. While the recommendation was not overwhelmingly enthusiastic, Provenge clears one hurdle on its way...Continue reading